Literature DB >> 12440379

Inactivation of intracellular Rho to stimulate axon growth and regeneration.

Benjamin Ellezam1, Catherine Dubreuil, Matthew Winton, Leanna Loy, Pauline Dergham, Inmaculada Sellés-Navarro, Lisa McKerracher.   

Abstract

Our studies indicate that the small GTPase Rho is an important intracellular target for promoting axon regrowth after injury. In tissue culture, inactivation of the Rho signaling pathway is effective in promoting neurite growth on growth inhibitory CNS substrates by two different methods: inactivation of Rho with C3 transferase, and inactivation by dominant negative mutation of Rho. In vivo, we have documented the regeneration of transfected axons after treatment with C3 in two different animals models, microcrush lesion of the adult rat optic nerve, and over-hemisection of adult mouse spinal cord. Mice treated with C3 after SCI showed impressive functional recovery, notwithstanding the fact that mice differ from rats in their response to spinal cord injury, especially in the extent of cavitation at the lesion site (Steward et al., 1999). It remains to be determined to what extent the regeneration of specific descending and ascending spinal axons contribute to the recovery, and whether inactivation of Rho enhances the spontaneous plasticity of axonal and dendritic remodeling after SCI. Inactivation of Rho with C3 to promote regeneration and functional recovery after SCI is simple, and our studies reveal the potential for a new, straightforward technique to promote axon regeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12440379     DOI: 10.1016/s0079-6123(02)37028-6

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  29 in total

1.  Autoantobodies activate small GTPase RhoA to modulate neurite outgrowth.

Authors:  Kazim A Sheikh
Journal:  Small GTPases       Date:  2011-07-01

2.  Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.

Authors:  Ping Yang; Hui-zhong Wen; Jin-hai Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-12       Impact factor: 6.150

3.  Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT.

Authors:  Brad A Bryan; Dianne C Mitchell; Lei Zhao; Wenbin Ma; Lewis J Stafford; Ba-Bie Teng; Mingyao Liu
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 4.  Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?

Authors:  Noam Y Harel; Stephen M Strittmatter
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

5.  Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth.

Authors:  Gang Zhang; Helmar C Lehmann; Sowmia Manoharan; Mohammedali Hashmi; Sangwoo Shim; Guo-Li Ming; Ronald L Schnaar; Pablo H Lopez; Nataliia Bogdanova; Kazim A Sheikh
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

6.  Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.

Authors:  Xiangmin Peng; Zhigang Zhou; Jian Hu; David J Fink; Marina Mata
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

7.  MicroRNA miR-133b is essential for functional recovery after spinal cord injury in adult zebrafish.

Authors:  Young-Mi Yu; Kurt M Gibbs; Jonathan Davila; Neil Campbell; Simon Sung; Tihomira I Todorova; Seiji Otsuka; Hatem E Sabaawy; Ronald P Hart; Melitta Schachner
Journal:  Eur J Neurosci       Date:  2011-03-30       Impact factor: 3.386

8.  The role of RhoA in retrograde neuronal death and axon regeneration after spinal cord injury.

Authors:  Jianli Hu; Guixin Zhang; William Rodemer; Li-Qing Jin; Michael Shifman; Michael E Selzer
Journal:  Neurobiol Dis       Date:  2016-11-22       Impact factor: 5.996

9.  Targeting a dominant negative rho kinase to neurons promotes axonal outgrowth and partial functional recovery after rat rubrospinal tract lesion.

Authors:  Dongsheng Wu; Ping Yang; Xinyu Zhang; Juan Luo; Mohammed E Haque; John Yeh; Peter M Richardson; Yi Zhang; Xuenong Bo
Journal:  Mol Ther       Date:  2009-07-21       Impact factor: 11.454

10.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.